1+ hour, 39+ min ago  (111+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

2+ hour, 21+ min ago  (168+ words) Sarah Sammons, Co-Leader of Breast Oncology at UMGCCC and former Senior Physician at Dana-Farber, shared Paolo Tarantino’s, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, post on X, adding: “Tucatinib and TDXd are the two most effective drugs for…...

13+ hour, 24+ min ago  (146+ words) Sam Royston, Executive Director for Research and Policy at Marie Curie UK, shared a post on LinkedIn: ”At Marie Curie UK, research is key to driving improvements and innovation in palliative and end of life care. We’ve funded six new…...

5+ hour, 52+ min ago  (960+ words) A phase 2 study published in Clinical Breast Cancer evaluated whether combining tucatinib with trastuzumab deruxtecan could improve outcomes for patients with previously treated HER2-positive unresectable locally advanced or metastatic breast cancer. The study, known as HER2CLIMB-04, showed that the combination had…...

6+ hour, 37+ min ago  (1122+ words) On July 15, 2026, Representatives John Joyce, MD, Greg Murphy, MD, and Kim Schrier, MD, introduced the Patients First Act, a proposal designed to modernize the Medicare Access and CHIP Reauthorization Act and address growing concerns surrounding physician reimbursement, healthcare consolidation, administrative…...

5+ hour, 28+ min ago  (336+ words) Joshua Omale, Research and Programs Associate at Slum and Rural Health Initiative Network, shared on LinkedIn: Every Child Inherits a Design Why the Future of African Children is being shaped long before they can choose it. Every child enters a…...

6+ hour, 34+ min ago  (1383+ words) Cancer cells are defined not only by uncontrolled growth, but also by their ability to reshape the biological systems that normally keep cells functioning within strict limits. They continue multiplying when they should stop, ignore signals designed to control their…...

6+ hour, 14+ min ago  (168+ words) Juan W. Valle: A New App to Connect Cholangiocarcinoma Patients with Healthcare Providers Oncodaily Juan W. Valle: A New App to Connect Cholangiocarcinoma Patients with Healthcare Providers Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn: “The Cholangiocarcinoma…...

7+ hour, 41+ min ago  (126+ words) Cancer Institute NSW shared on LinkedIn: ”Graham was diagnosed with sarcoma in 2002 after discovering a lump in his left gluteus maximus. His treatment was urgent and included a biopsy, six cycles of chemotherapy, and surgery. More than two decades later,…...

6+ hour, 53+ min ago  (251+ words) New findings from the Phase III KEYNOTE-C93 trial suggest the answer may be yes. Patients with dMMR endometrial cancer have highly immunogenic tumors characterized by a large number of mutations that generate neoantigens capable of stimulating an immune response. These…...